v3 Template
S

Sigrid Therapeutics

Medtech / Healthcare ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$16.7M
Funding Rounds
3
Last Funding
2026-01-07

About Sigrid Therapeutics

Sigrid Therapeutics is a company pioneering a non-pharmaceutical approach to blood sugar control and weight management. Powered by their patented SiPore® technology, they aim to tackle the global rise in metabolic diseases such as prediabetes, diabetes, and obesity through clinically validated solutions that improve metabolic health safely and effectively.

Products & Services

Carb Fence™:A clinically validated medical food for prediabetes and diabetes, aimed at blood sugar and weight control. Regulatory clearance expected in Q2 2025 (U.S.) and Q2 2026 (EU). Reduces blood sugar spikes, supports weight loss, and preserves muscle mass.
Glucose Stabiliser:A non-invasive supplement for daily blood sugar and weight support, launched in Sweden and the U.S. with strong consumer retention. Available via e-commerce for long-term metabolic health.

Specialties

Metabolic Health Solutions Blood Sugar Control Weight Management Bioengineered Silica Technology (SiPore®) Non-Pharmaceutical Approaches

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital
A: 5000000
MR: -
FA: USD 5 million
FAN: 5000000
D: 2026-01-07
FD: 2026-01-07
-
2 RT: Rights Issue
T: -
FT: Rights Issue
A: 1060000
MR: -
FA: SEK10.6 million
FAN: 1060000
D: 2023-01-16
FD: 2023-01-16
1 investors
3 RT: Rights Issue
T: -
FT: Rights Issue
A: 10600000
MR: -
FA: SEK10.6 million
FAN: 10600000
D: 2023-01-16
FD: 2023-01-16
1 investors
Venture Capital Latest
2026-01-07
$5.0M
Rights Issue 2023-01-16
$1.1M
Rights Issue 2023-01-16
$10.6M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Stephan Rössner

M.D., Ph.D.

K

Kirsi Pietiläinen

M.D., Ph.D.

B

Benjamin Boyd

Ph.D.

J

Jørgen Thorball

M.D., Ph.D.

M

Mikael Rydén

M.D., Ph.D.

A

Arvo Hanni

M.D., Ph.D.

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Sigrid Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Medtech / Healthcare
Company Size
~460 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro